GILD and AMGN Related Headlines
Go Back- Jefferies Starts Amgen (AMGN) at Hold
- Jefferies Starts Vertex (VRTX) at Buy
- Jefferies Starts Gilead Sciences (GILD) at Buy
- Barclays launches U.S. biopharma coverage with four preferred picks
- 14 of 17 Leading Drug Manufactures Now Part of Trump Most Favored Nation Efforts
- Trump to announce prescription drug price agreements
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
- RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'
- Trump demands pharma CEOs lower drug prices within 60 days
- Trump Posts Letters to Regeneron, Merck, AstraZeneca, GSK, Pfizer, Novo Nordisk, Amgen, Bristol-Myears, AbbVie, Novartis, Gilead, J&J on Truth Social
- Biotech stocks dip as Trump administration mulls patent fee overhaul
- U.S. large biotech stocks Q2 earnings preview
